All Type of News
Largest shareholder’s average share ratio was 24.22%
It was observed the largest shareholder’s average share ratio of the top 20 pharmaceutical companies was 24.22%. Among the companies, a company which had the highest ratio was Green Cross.
According to recent officia...
“Reducing pressure of medical expenses” picked as prioritized issue to address
The Research Institute For Healthcare Policy(Head Jae-wook Choi), Korean Medical Association(President Moo-jin Choo), announced data that compared healthcare-related pledges of each political party facing the 4.13 gen...
MFDS to support patent consulting for pharmaceutical companies less than KRW 100 billion
The Ministry of Food and Drug Safety(MFDS) has visualized the consulting business for the first time to help small and medium-sized pharmaceutical companies which will challenge pharmaceutical patents.
It was confirm...
Last year’s sales reports of multinational companies branched in Korea
Last year, multinational pharmaceutical companies were known to record sales hits.
According to the 2015 audit reports turned in by major multinational companies to the Financial Supervisory Service, sales of many mu...
Zykadia Cap passes first wall of insurance benefit registration
A Novartis’s lung cancer therapy, Zykadia Cap(ceritinib) received a ‘insurance benefit adequacy’ evaluation as applied by a special case to be exempted in economic evaluation. It, thus, became the 5th drug which passe...
Hair loss therapies 70% cheaper than Propecia
Hair loss therapies will be sold with cheaper prices due to generic launches. A drug that is 70% cheaper at most than Propecia(MSD), a drug sold the most in Korea, launched.
According to the industry on the 7th, a n...
Disclosure of rebate types only brings damages to each pharmaceutical
The Korea Pharmaceutical Manufacturers Association has decided to unveil the secret survey result to sort out pharmaceutical companies suspicious of illegal rebates at the board meeting on the 6th.
Thus, there is now...
Along with Hanmi’s achievement, last year’s foreign exports increased
It was observed exports of listed pharmaceutical companies were significantly increased along with the Hanmi Pharm’ large-scale new drug technology exports.
In 2014, exports accounted only for 11.9% of the total sa...
Novo Nordisk South Korea’s CP violation, expecting ‘large-scale personnel transfers’
Novo Nordisk South Korea is having a rough time as violating the Compliance Program(CP).
According to the industry concerned on the 6th, the Novo Nordisk headquarters dispatched an external audit agency last month t...
MSD Korea’s unfair illegal actions bounced back to domestic companiesThe illegal action of a large multinational pharmaceutical company has been bounced back to domestic ones.
Particularly, in the circumstance where the Fair Trade Commission(FT...
|
